Biomarkers in inflammatory and noninflammatory cardiomyopathy

Herz

Volumn 34, Issue 8, 2009, Pages 614-623

  Noutsias, Michel ^a   Pankuweit, Sabine ^a   Maisch, Bernhard ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Biomarkers; Cardiac magnetic resonance (CMR); Diagnosis; Dilated cardiomyopathy; Endomyocardial biopsy (EMB); Immune system; Immunomodulatory therapy; Inflammatory cardiomyopathy; Myocarditis; Prognosis; Viral infection

Indexed keywords

BETA INTERFERON; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CREATINE KINASE; CYTOKINE; GADOLINIUM; RECOMBINANT GAMMA INTERFERON; TROPONIN;

CARDIOLOGY; CARDIOMYOPATHY; CONGESTIVE CARDIOMYOPATHY; CORONARY CARE UNIT; DISEASE ACTIVITY; DISEASE MARKER; HEART FAILURE; HEART MUSCLE BIOPSY; HEART MUSCLE NECROSIS; HISTOPATHOLOGY; HUMAN; IMAGE ENHANCEMENT; IMMUNOHISTOLOGY; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY CARDIOMYOPATHY; MYOCARDITIS; NONINFLAMMATORY CARDIOMYOPATHY; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; POLYMERASE CHAIN REACTION; PROGNOSIS; REVIEW; SAMPLING ERROR; TREATMENT RESPONSE; VIRUS GENOME; VIRUS MYOCARDITIS;

BIOLOGICAL MARKERS; CARDIOMYOPATHIES; DIAGNOSIS, DIFFERENTIAL; HUMANS; MYOCARDITIS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 73649090005     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-009-3318-2     Document Type: Review

References (74)

1. P. Richardson W. McKenna M. Bristow, et al. 1996 Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies Circulation 93 841 842 1:STN:280:DyaK287nvFSisg%3D%3D 8598070
2. A.L. Caforio F. Calabrese A. Angelini, et al. 2007 A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis Eur Heart J 28 1326 1333 10.1093/eurheartj/ehm076 17493945 (Pubitemid 47355977)
3. S. Pankuweit R. Moll U. Baandrup, et al. 2003 Prevalence of the parvovirus B19 genome in endomyocardial biopsy specimens Hum Pathol 34 497 503 10.1016/S0046-8177(03)00078-9 12792925 (Pubitemid 36666817)
4. U. Kühl M. Pauschinger T. Bock, et al. 2003 Parvovirus B19 infection mimicking acute myocardial infarction Circulation 108 945 950 10.1161/01.CIR.0000085168.02782.2C 12925460 (Pubitemid 37048223)
5. U. Kühl M. Pauschinger M. Noutsias, et al. 2005 High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction Circulation 111 887 889 10.1161/01.CIR.0000155616.07901.35 15699250 (Pubitemid 40279890)
6. H. Baccouche H. Mahrholdt G. Meinhardt, et al. 2009 Diagnostic synergy of non-invasive cardiovascular magnetic resonance and invasive endomyocardial biopsy in troponin-positive patients without coronary artery disease Eur Heart J 30 23 2869 2879 10.1093/eurheartj/ehp328 1:CAS:528:DC%2BD1MXhsFart77F 19696191
7. D.A. Morrow J.A. de Lemos 2007 Benchmarks for the assessment of novel cardiovascular biomarkers Circulation 115 949 952 10.1161/CIRCULATIONAHA.106. 683110 17325253 (Pubitemid 46328287)
8. Biomarker Definitions Working Group. 2001 Biomarkers and surrogate endpoints: preferred definitions and conceptual framework Clin Pharmacol Ther 69 89 95 10.1067/mcp.2001.113989 (Pubitemid 32225406)
9. B. Maisch B. Bültman S. Factor, et al. 1999 World Heart Federation consensus conferences's definition of inflammatory cardiomyopathy (myocarditis): report from two expert commitees on histology and viral cardiomyopathy Heartbeat 4 3 4
10. M. Holzmann A. Nicko U. Kühl, et al. 2008 Complication rate of right ventricular endomyocardial biopsy via the femoral approach: a retrospective and prospective study analyzing 3048 diagnostic procedures over an 11-year period Circulation 118 1722 1728 10.1161/CIRCULATIONAHA.107.743427 18838566
11. L.T. Cooper K.L. Baughman A.M. Feldman, et al. 2007 The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Circulation 116 2216 2233 10.1161/CIRCULATIONAHA.107.186093 17959655 (Pubitemid 350060359)
12. H.T. Aretz 1987 Myocarditis: the Dallas criteria Hum Pathol 18 619 624 10.1016/S0046-8177(87)80363-5 1:STN:280:DyaL2s3kvVOisw%3D%3D 3297992
13. M. Grogan M.M. Redfield K.R. Bailey, et al. 1995 Long-term outcome of patients with biopsy-proved myocarditis: comparison with idiopathic dilated cardiomyopathy J Am Coll Cardiol 26 80 84 10.1016/0735-1097(95)00148-S 1:STN:280:DyaK2MzhvVertQ%3D%3D 7797779
14. I. Kindermann M. Kindermann R. Kandolf, et al. 2008 Predictors of outcome in patients with suspected myocarditis Circulation 118 639 648 10.1161/CIRCULATIONAHA.108.769489 18645053
15. B.E. Strauer R. Kandolf G. Mall, et al. 1996 Myocarditis - cardiomyopathy. Consensus report of the German Association for Internal Medicine, presented at the 100th annual meeting, Wiesbaden, 13 April 1994 Acta Cardiol 51 347 371 1:STN:280:DyaK2s%2FktlyhsA%3D%3D 8888893
16. J.G. Shanes J. Ghali M.E. Billingham, et al. 1987 Interobserver variability in the pathologic interpretation of endomyocardial biopsy results Circulation 75 401 405 1:STN:280:DyaL2s7gtlGisw%3D%3D 3802444
17. A.J. Hauck D.L. Kearney W.D. Edwards 1989 Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error Mayo Clin Proc 64 1235 1245 1:STN:280:DyaK3c%2FotV2mtA%3D%3D 2593714
18. M.E. Billingham 1989 Myocarditis and endomyocardial biopsy Ann Intern Med 110 165 166 1:STN:280:DyaL1M%2FnsFCktA%3D%3D 2909208
19. J.W. Mason J.B. O'Connell A. Herskowitz, et al. 1995 A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators N Engl J Med 333 269 275 10.1056/NEJM199508033330501 1:CAS:528:DyaK2MXntlKhtrc%3D 7596370
20. B. Maisch F. Camerini H.P. Schultheiss 1995 Immunosuppressive therapy for myocarditis N Engl J Med 333 1713 10.1056/NEJM199512213332513 1:STN:280:DyaK28%2FotlKmtA%3D%3D 7477236 (Pubitemid 26001965)
21. L.T. Cooper Jr G.J. Berry R. Shabetai 1997 Idiopathic giant-cell myocarditis - natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators N Engl J Med 336 1860 1866 10.1056/NEJM199706263362603 9197214 (Pubitemid 27263973)
22. Schultheiss HP, Noutsias M, Kühl U, et al. Myocarditis and viral cardiomyopathy. In: Camm AJ, Lüscher TF, Serruys PW, eds. The ESC textbook of cardiovascular medicine. Oxford: Blackwell, 2006:490-501
23. M. Noutsias M. Pauschinger H.P. Schultheiss, et al. 2002 Advances in the immunohistological diagnosis of inflammatory cardiomyopathy Eur Heart J Suppl 4 I54 I62 10.1016/S1520-765X(02)90112-4 (Pubitemid 35434748)
24. U. Kühl M. Noutsias B. Seeberg, et al. 1996 Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy Heart 75 295 300 10.1136/hrt.75.3.295 8800996 (Pubitemid 26094969)
25. M. Noutsias B. Seeberg H.P. Schultheiss, et al. 1999 Expression of cell adhesion molecules in dilated cardiomyopathy: evidence for endothelial activation in inflammatory cardiomyopathy Circulation 99 2124 2131 1:CAS:528:DyaK1MXjtVOhuro%3D 10217652
26. B. Maisch I. Portig A. Ristic, et al. 2000 Definition of inflammatory cardiomyopathy (myocarditis): on the way to consensus. A status report Herz 25 200 209 10.1007/s000590050007 1:STN:280:DC%2BD3cvnt1CgsA%3D%3D 10904839 (Pubitemid 30422164)
27. G. Hufnagel S. Pankuweit A. Richter, et al. 2000 The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID). First epidemiological results Herz 25 279 285 10.1007/s000590050021 1:STN:280:DC%2BD3cvnt1CntA%3D%3D 10904853 (Pubitemid 30422178)
28. A. Frustaci M.A. Russo C. Chimenti 2009 Randomized study on the efficacy of immunosuppressive therapy in patients with virus- negative inflammatory cardiomyopathy: the TIMIC study Eur Heart J 30 1995 2002 10.1093/eurheartj/ ehp249 1:CAS:528:DC%2BD1MXhtVals7bP 19556262
29. H. Mahrholdt C. Goedecke A. Wagner, et al. 2004 Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology Circulation 109 1250 1258 10.1161/01.CIR.0000118493.13323.81 14993139 (Pubitemid 38379570)
30. S. Pankuweit A. Richter V. Ruppert, et al. 2009 Classification of cardiomyopathies and indication for endomyocardial biopsy revisited Herz 34 55 62 10.1007/s00059-009-3200-2 19214409
31. T.A. Springer 1990 Adhesion receptors of the immune system Nature 346 425 434 10.1038/346425a0 1:CAS:528:DyaK3cXltlSiurg%3D 1974032 (Pubitemid 20251059)
32. M. Noutsias M. Pauschinger H.P. Schultheiss, et al. 2003 Cytotoxic perforin+ and TIA-1+ infiltrates are associated with cell adhesion molecule expression in dilated cardiomyopathy Eur J Heart Fail 5 469 479 10.1016/S1388-9842(03)00037-0 1:CAS:528:DC%2BD3sXmt1Kitb8%3D 12921808 (Pubitemid 37021641)
33. R. Wojnicz E. Nowalany-Kozielska C. Wojciechowska, et al. 2001 Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results Circulation 104 39 45 10.1161/hc3001.095127 1:CAS:528:DC%2BD3MXls1emsLs%3D 11435335
34. A. Herskowitz A. Ahmed-Ansari D.A. Neumann, et al. 1990 Induction of major histocompatibility complex antigens within the myocardium of patients with active myocarditis: a nonhistologic marker of myocarditis J Am Coll Cardiol 15 624 632 1:STN:280:DyaK3c7lsVGitA%3D%3D 2406319
35. T. Ino M. Kishiro M. Okubo, et al. 1997 Late persistent expressions of ICAM-1 and VCAM-1 on myocardial tissue in children with lymphocytic myocarditis Cardiovasc Res 34 323 328 10.1016/S0008-6363(97)00002-3 1:STN:280: DyaK2szkvFKhtw%3D%3D 9205546 (Pubitemid 27241577)
36. M. Noutsias M. Pauschinger K. Ostermann, et al. 2002 Digital image analysis system for the quantification of infiltrates and cell adhesion molecules in inflammatory cardiomyopathy Med Sci Monit 8 MT59 MT71 1:CAS:528:DC%2BD38XltFaltrY%3D 12011783
37. J.E. Parrillo 2001 Inflammatory cardiomyopathy (myocarditis): which patients should be treated with anti-inflammatory therapy? Circulation 104 4 6 10.1161/hc2601.092124 1:STN:280:DC%2BD3MznvVyktw%3D%3D 11435327
38. M. Gutberlet B. Spors T. Thoma, et al. 2008 Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence Radiology 246 401 409 10.1148/radiol.2461062179 18180335
39. U. Kühl H.P. Schultheiss 1995 Treatment of chronic myocarditis with corticosteroids Eur Heart J 16 168 172 8682089
40. M. Noutsias M. Rohde A. Block, et al. 2008 Preamplification techniques for real-time RT-PCR analyses of endomyocardial biopsies BMC Mol Biol 9 3 10.1186/1471-2199-9-3 18194512 (Pubitemid 351330974)
41. U. Kühl M. Pauschinger B. Seeberg, et al. 2005 Viral persistence in the myocardium is associated with progressive cardiac dysfunction Circulation 112 1965 1970 10.1161/CIRCULATIONAHA.105.548156 16172268 (Pubitemid 41377415)
42. H.J. Why B.T. Meany P.J. Richardson, et al. 1994 Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy Circulation 89 2582 2589 1:STN:280:DyaK2c3msFeisg%3D%3D 8205668
43. S. Fujioka Y. Kitaura A. Ukimura, et al. 2000 Evaluation of viral infection in the myocardium of patients with idiopathic dilated cardiomyopathy J Am Coll Cardiol 36 1920 1926 10.1016/S0735-1097(00)00955-4 1:CAS:528: DC%2BD3MXhs1Cl 11092665 (Pubitemid 30844106)
44. C. Baboonian T. Treasure 1997 Meta-analysis of the association of enteroviruses with human heart disease Heart 78 539 543 1:STN:280: DyaK1c7jtFKnsQ%3D%3D 9470867
45. M. Pauschinger N.E. Bowles F.J. Fuentes-Garcia, et al. 1999 Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction Circulation 99 1348 1354 1:STN:280:DyaK1M7nslWgsw%3D%3D 10077520
46. N.E. Bowles J. Ni D.L. Kearney, et al. 2003 Detection of viruses in myocardial tissues by polymerase chain reaction. evidence of adenovirus as a common cause of myocarditis in children and adults J Am Coll Cardiol 42 466 472 10.1016/S0735-1097(03)00648-X 12906974 (Pubitemid 36951713)
47. B.D. Bultmann K. Klingel K. Sotlar, et al. 2003 Parvovirus B19: a pathogen responsible for more than hematologic disorders Virchows Arch 442 8 17 12536309
48. M. Pauschinger A. Doerner U. Kühl, et al. 1999 Enteroviral RNA replication in the myocardium of patients with left ventricular dysfunction and clinically suspected myocarditis Circulation 99 889 895 1:STN:280: DyaK1M7lt1SksQ%3D%3D 10027811
49. M. Streitz M. Noutsias R. Volkmer, et al. 2008 NS1 specific CD8+ T-cells with effector function and TRBV11 dominance in a patient with parvovirus B19 associated inflammatory cardiomyopathy PLoS ONE 3 e2361 10.1371/journal.pone. 0002361 18523634
50. U. Kühl D. Lassner M. Pauschinger, et al. 2008 Prevalence of erythrovirus genotypes in the myocardium of patients with dilated cardiomyopathy J Med Virol 80 1243 1251 10.1002/jmv.21187 18461615 (Pubitemid 351706004)
51. Kuethe F, Lindner J, Matschke K, et al. Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis. Clin Infect Dis 2009:in press.
52. F. Escher S. Modrow T. Sabi, et al. 2008 Parvovirus B19 profiles in patients presenting with acute myocarditis and chronic dilated cardiomyopathy Med Sci Monit 14 CR589 597 19043365
53. Y. Li T. Bourlet L. Andreoletti, et al. 2000 Enteroviral capsid protein VP1 is present in myocardial tissues from some patients with myocarditis or dilated cardiomyopathy Circulation 101 231 234 1:CAS:528:DC%2BD3cXptVamtQ%3D%3D 10645916
54. R. Dettmeyer A. Baasner M. Schlamann, et al. 2004 Role of virus-induced myocardial affections in sudden infant death syndrome: a prospective postmortem study Pediatr Res 55 947 952 10.1203/01.pdr.0000127022.45831.54 15155864 (Pubitemid 38661785)
55. F. Escher U. Kühl T. Sabi, et al. 2008 Immunohistological detection of parvovirus B19 capsid proteins in endomyocardial biopsies from dilated cardiomyopathy patients Med Sci Monit 14 CR333 338 18509278
56. U. Kühl M. Pauschinger P.L. Schwimmbeck, et al. 2003 Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction Circulation 107 2793 2798 10.1161/01.CIR.0000072766. 67150.51 12771005 (Pubitemid 36705988)
57. M.G. Friedrich O. Strohm J. Schulz-Menger, et al. 1998 Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis Circulation 97 1802 1809 1:STN:280: DyaK1c3msVKqug%3D%3D 9603535
58. H. Abdel-Aty P. Boye A. Zagrosek, et al. 2005 Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches J Am Coll Cardiol 45 1815 1822 10.1016/j.jacc.2004.11.069 15936612 (Pubitemid 40779862)
59. H. Mahrholdt A. Wagner R.M. Judd, et al. 2005 Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies Eur Heart J 26 1461 1474 10.1093/eurheartj/ehi258 15831557 (Pubitemid 41373486)
60. R.G. Assomull S.K. Prasad J. Lyne, et al. 2006 Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy J Am Coll Cardiol 48 1977 1985 10.1016/j.jacc.2006.07.049 17112987 (Pubitemid 44738448)
61. M.G. Friedrich U. Sechtem J. Schulz-Menger, et al. 2009 Cardiovascular magnetic resonance in myocarditis: a JACC White Paper J Am Coll Cardiol 53 1475 1487 10.1016/j.jacc.2009.02.007 19389557
62. M. Noutsias U. Kühl D. Lassner, et al. 2007 Parvovirus B19-associated active myocarditis with biventricular thrombi - results of endomyocardial biopsy investigations and cardiac magnetic resonance imaging Circulation 115 e378 380 10.1161/CIRCULATIONAHA.106.667360 17404165 (Pubitemid 46648626)
63. A. Zagrosek R. Wassmuth H. Abdel-Aty, et al. 2008 Relation between myocardial edema and myocardial mass during the acute and convalescent phase of myocarditis - a CMR study J Cardiovasc Magn Reson 10 19 10.1186/1532-429X-10-19 18447954
64. V. Hombach N. Merkle J. Torzewski, et al. 2009 Electrocardiographic and cardiac magnetic resonance imaging parameters as predictors of a worse outcome in patients with idiopathic dilated cardiomyopathy Eur Heart J 30 2011 2018 10.1093/eurheartj/ehp293 19633015
65. A. Zagrosek H. Abdel-Aty P. Boye, et al. 2009 Cardiac magnetic resonance monitors reversible and irreversible myocardial injury in myocarditis JACC Cardiovasc Imaging 2 131 138 10.1016/j.jcmg.2008.09.014 19356545
66. J. Schulz-Menger B. Maisch H. Abdel-Aty, et al. 2007 Integrated biomarkers in cardiomyopathies: cardiovascular magnetic resonance imaging combined with molecular and immunologic markers - a stepwise approach for diagnosis and treatment Herz 32 458 472 10.1007/s00059-007-3046-4 17882371 (Pubitemid 47468955)
67. E. Braunwald 2008 Biomarkers in heart failure N Engl J Med 358 2148 2159 10.1056/NEJMra0800239 1:CAS:528:DC%2BD1cXlvFCrsL8%3D 18480207 (Pubitemid 351679601)
68. K. Dickstein A. Cohen-Solal G. Filippatos, et al. 2008 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur J Heart Fail 10 933 989 10.1016/j.ejheart. 2008.08.005 18826876
69. S. von Haehling J.C. Schefold M. Lainscak, et al. 2009 Inflammatory biomarkers in heart failure revisited: much more than innocent bystanders Heart Fail Clin 5 549 560 10.1016/j.hfc.2009.04.001
70. B. Lauer C. Niederau U. Kühl, et al. 1997 Cardiac troponin T in patients with clinically suspected myocarditis J Am Coll Cardiol 30 1354 1359 10.1016/S0735-1097(97)00317-3 1:STN:280:DyaK1c%2FhtVChsA%3D%3D 9350939 (Pubitemid 27501457)
71. P. Ammann B. Naegeli E. Schuiki, et al. 2003 Long-term outcome of acute myocarditis is independent of cardiac enzyme release Int J Cardiol 89 217 222 12767545
72. X. Freixa A. Sionis A. Castel, et al. 2009 Low troponin-I levels on admission are associated with worse prognosis in patients with fulminant myocarditis Transplant Proc 41 2234 2236 10.1016/j.transproceed.2009.06.012 1:CAS:528:DC%2BD1MXhtVKmur3O 19715884
73. B. Levine J. Kalman L. Mayer, et al. 1990 Elevated circulating levels of tumor necrosis factor in severe chronic heart failure N Engl J Med 323 236 241 1:STN:280:DyaK3czgvF2isA%3D%3D 2195340
74. M. Rauchhaus A.J. Coats S.D. Anker 2000 The endotoxin-lipoprotein hypothesis Lancet 356 930 933 10.1016/S0140-6736(00)02690-8 1:CAS:528: DC%2BD3cXmslKlsbw%3D 11036910